Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells by Inducing Apoptosis

BACKGROUND: Therapeutic approach by treatment with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) like gefitinib or erlotinib to non-small cell lung cancer (NSCLC) patients has been limited due to emergence of acquired drug resistance. Our study was aimed to investigate whet...

Descripción completa

Detalles Bibliográficos
Autor principal: Jeong, Chul-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384715/
https://www.ncbi.nlm.nih.gov/pubmed/25853104
http://dx.doi.org/10.15430/JCP.2015.20.1.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384715/
https://www.ncbi.nlm.nih.gov/pubmed/25853104
http://dx.doi.org/10.15430/JCP.2015.20.1.57

Ejemplares similares